J-Lex

Tresiba Injection FlexTouch

Tresiba Injection FlexTouch contains insulin degludec (recombinant), an ultra-long-acting insulin from Novo Nordisk Pharma, used for glycemic control in adults and children with diabetes mellitus. This injectable pen, YJ code 2492419G1021, contains 300 units per kit.

← Back to search

Need more detailed information?

Contact TASAKI PHARMA for inquiries about this medicine (English support available).

Contact us about this drug →

More with the same ingredient

More from this manufacturer